• Bestatin (Ubenimex): Mechanism & Research Use

  2026-08-15

  Bestatin, also called Ubenimex, is a research inhibitor of aminopeptidase B, leucine aminopeptidase, and selected aminopeptidase N-related activities. Its reported biochemical potency, cell-assay use, storage requirements, and in vivo research boundaries support controlled applications in aminopeptidase activity measurement, apoptosis assay design, multidrug resistance research, and cancer research.

• Biotin (Vitamin B7) for STING Assay Design

  2026-08-14

  Biotin and Vitamin B7 are more than metabolic cofactors: they can support modular assay architectures for studying DNA-sensing proteins. This article connects biotin chemistry with shrimp STING research while distinguishing validated findings from proposed experimental workflows.

• Okadaic acid (A4540): PP1/PP2A Workflow Guide

  2026-08-14

  Okadaic acid (SKU A4540) provides a concentration-dependent way to inhibit PP2A predominantly at low nanomolar levels and PP1 at higher nanomolar levels in biochemical and cell-based studies. It is useful for phosphorylation signaling and apoptosis workflows, but it should not be treated as a universal phosphatase inhibitor or as evidence of pathway-specific causality without appropriate controls.

• BACE Inhibition and Synaptic Transmission in Neurons

  2026-08-13

  Satir and colleagues tested whether partial β-secretase inhibition could lower amyloid-β production without disrupting neuronal communication. Using primary cortical rat neurons, optical electrophysiology, and secreted Aβ measurements, they found that reductions below 50% preserved synaptic transmission, whereas stronger inhibition impaired it.

• DGLA–ACSL4 Ferroptosis in AML Cells

  2026-08-13

  A study in Translational Oncology identifies dihomo-γ-linolenic acid (DGLA) as a ferroptosis-inducing lipid vulnerability in acute myeloid leukemia (AML). By combining targeted metabolomics, ACSL4 loss-of-function experiments, and in vivo dietary intervention, the work connects fatty-acid remodeling with ferroptosis sensitivity and suggests a preclinical strategy for AML research.

• Carbapenemase Gene Transfer in CREC Across Guangdong

  2026-08-12

  Chen et al. characterize carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong, combining gene localization, antimicrobial susceptibility, conjugation, mobile-element analysis, and ERIC-PCR typing. The study identifies plasmid-associated blaNDM-1, extensive multidrug resistance, and efficient in vitro gene transfer as major features relevant to infection-control surveillance.

• CCT007093: Practical PPM1D Inhibitor Workflows

  2026-08-12

  CCT007093 is a research-ready PPM1D inhibitor for connecting phosphatase activity with P38 MAPK signaling, cell viability, and inflammatory cell death. Its value is strongest in orthogonal workflows that combine biochemical inhibition, early phospho-P38 measurements, viability assays, and pathway-rescue controls.

• Lysosomal β-Galactosidase Staining Kit in Senescence

  2026-08-11

  Learn how the Lysosomal β-Galactosidase Staining Kit supports interpretation-ready cell senescence staining. This guide connects lysosomal enzyme activity assay design with SLC25A1-driven cisplatin resistance while defining controls, artifacts, and biological limits.

• Chlorin e6: From ROS to Translation

  2026-08-10

  Chlorin e6 is more than a laboratory photosensitizer: it is a translational platform for light-controlled reactive oxygen species generation. This article connects anticancer photodynamic therapy with Ce6-enabled wound biomaterials, showing how molecular quality, spatial presentation, irradiation design, and biological readouts can shape the path from mechanistic evidence to practical research strategy.

• Fludarabine Workflows for DNA Synthesis Inhibition

  2026-08-09

  Build reproducible Fludarabine assays around intracellular F-ara-ATP formation, DNA replication blockade, cell-cycle analysis, and apoptosis readouts. This practical guide connects leukemia and multiple myeloma models with genotype-aware experimental design and troubleshooting strategies.

• β-Elemene Workflows for Adipogenesis Research

  2026-08-08

  β-Elemene, also known as Levo-β-elemene, supports a practical workflow that connects lipid accumulation, insulin resistance, glucose handling, and AMPK biology in 3T3-L1 cells. This guide translates the latest adipogenesis findings into dosing, assay-selection, formulation, and troubleshooting strategies while clarifying how the compound can complement neuroprotection and apoptosis research.

• Protease Inhibitor Cocktail: EDTA-Free 200X Guide

  2026-08-07

  This EDTA-free Protease Inhibitor Cocktail helps limit protein degradation during extraction and downstream assays, including Western blotting, co-immunoprecipitation, pull-down, and kinase workflows. It is supplied as a 200X solution in DMSO and should not be used without compatibility testing when DMSO can disrupt the assay or when protease inhibition is unnecessary.

• Applied Workflows with the Live-Dead Bacterial Staining Kit

  2026-08-07

  Explore how the Live-Dead Bacterial Staining Kit revolutionizes viability assessment in complex infection models and antibacterial material testing. Discover protocol enhancements, troubleshooting solutions, and direct insights from jaw osteomyelitis nanoplatform research.

• Escitalopram for Antidepressant Research: Protocols & Innova

  2026-08-06

  Escitalopram (Lexapro) is a gold-standard SSRI for probing serotonergic signaling and translational models of depression and anxiety. This article details advanced experimental workflows, protocol optimizations, and troubleshooting strategies that leverage APExBIO's high-purity Escitalopram for reproducible, data-rich neuroscience research.

• Practical Guidance for Triamcinolone (B1859) in Research Wor

  2026-08-06

  Triamcinolone (SKU B1859) is a synthetic glucocorticoid agonist optimized for controlled studies of glucocorticoid signaling pathways, anti-inflammatory responses, and immunosuppression in vitro. This product is not suitable for diagnostic or clinical use, and its technical application requires strict adherence to solubility and storage protocols for reproducible results.

453 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page